跳至主要内容
临床试验/NCT05971004
NCT05971004已完成不适用

Effectiveness of Hydrolyzed Collagen Peptide Injection for the Treatment of Collateral Ligament Pain: A Randomized Controlled Trial

Tiss'You srl1 个研究点 分布在 1 个国家目标入组 62 人开始时间: 2022年4月13日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
62
试验地点
1
主要终点
WOMAC

研究概览

简要总结

Conducted by Binh Luu Thi, Lan Tran Thi, and Minh Hang Hoang Thi at Thai Nguyen National Hospital, the study investigates a new approach to treating persistent collateral ligament pain, common among athletes. The research examines the therapeutic use of hydrolyzed collagen peptide injections, a treatment that addresses pain and inflammation in ways previous methods have not.

The study involves a randomized controlled trial with 62 patients, all diagnosed with inflammation in the collateral ligament site. The patients are split into two groups: one receiving collagen injections alongside oral painkillers and the other receiving depo-medrol injections with oral painkillers.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Single (Participant)

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • age above 18 years,
  • lateral knee pain with a duration of 3 months or longer,
  • ultrasound evidence of inflammation of the femoral condyle attachment point,
  • agreement to participate in the study

排除标准

  • infection,
  • dermatitis at the site of the inflammation,
  • damage to surrounding knee structures,
  • history of chronic inflammatory arthritis (such as gout or rheumatoid arthritis),
  • local corticosteroid injection within 3 months before participating in the study.

研究组 & 干预措施

Collagen Peptide Group

Experimental

The Collagen Peptide Group (31 patients) received oral pain relievers (paracetamol and anti-inflammatory NSAIDs) for 3-7 days (if the pain was severe) and one injection of collagen peptide solution (Tiss'You, Republic of San Marino) at the site of the inflamed ligament attachment point (femoral condyle).

干预措施: Arthrys (Collagen Peptide solution) (Device)

Cortison Group

Active Comparator

The Cortison Group (31 patients) received oral painkillers (paracetamol and anti-inflammatory NSAIDs) for 3-7 days (if the pain was severe) and one injection of depo-medrol at the site of inflamed ligament attachment point (femoral condyle), combined with oral slow-acting symptomatic drugs (glucosamine 1500mg, atrodar 50mg) for 3 consecutive months.

干预措施: Depo medrol (Drug)

结局指标

主要结局

WOMAC

时间窗: 6 months

Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) assessing functionality from 0 to 96 for the total WOMAC where 0 represents the best health status and 96 the worst possible status.

次要结局

  • VAS (Visual Analogue Pain)(Baseline, 3 months, 6 months)
  • Ultrasound(Baseline, 3 months, 6 months)
  • Likert(Baseline, 6 months)
  • WOMAC(Baseline, 3 months)

研究者

发起方
Tiss'You srl
申办方类型
Industry
责任方
Principal Investigator
主要研究者

Prof. Binh Luu Thi

Prof

Tiss'You srl

研究点 (1)

Loading locations...

相似试验